In a study published in Scientific Reports, researchers engineer long-lasting GLP-1 receptor agonists by fusing GLP-1 with an HSA-binding protein. These chimeric molecules show promise for the treatment of type 2 diabetes due to their stability, functionality, and high affinity for the GLP-1 receptor and human serum albumin.
Two years since Dobbs, reproductive freedom must be protected from assault
It’s been two years since America’s highest court removed a constitutional right — for the first time in history — that Americans have relied on
June 24, 2024